2016

1 – Parker W, Berek JS, Pritts E, Olive D, Kaunitz AM, Chalas E, Clarke-Pearson D, Goff B, Bristow R, Taylor HS, Farias-Eisner R, Fader AN, Maxwell GL, Goodwin SC, Love S, Gibbons WE, Foshag LJ, Leppert PC, Norsigian J, Nager CW, Johnson T, Guzick DS, As-Sanie S, Paulson RJ, Farquhar C, Bradley L, Scheib SA, Bilchik AJ, Rice LW, Dionne C, Jacoby A, Ascher-Walsh C, Kilpatrick SJ, Adamson GD, Siedhoff M, Israel R, Fidela Paraiso M, Frumovitz MM, Lurain JR, Al-Hendy A, Benrubi GI, Raman SS, Kho RM, Anderson TL, Reynolds RK, DeLancey J. An open letter to the Food and Drug Administration regarding the use of morcellation procedures in women having surgery for presumed uterine myomas. J Minim Invasive Gynecol 2016;Epub:Jan 8.

https://www.ncbi.nlm.nih.gov/pubmed/26773577

2 – Flaherty DC, Lavotshkin S, Jalas JR, Torisu-Itakura H, Kirchoff DD, Sim MS, Lee DJ, Bilchik AJ. Prognostic utility of immunoprofiling in colon cancer: results from a prospective, multicenter nodal ultrastaging trial. J Am Coll Surg 2016;Epub:Mar 18.

https://www.ncbi.nlm.nih.gov/pubmed/27282965

3 – Protic M, Veljkovic R, Bilchik AJ, Popovic A, Kresoja M, Nissan A, Avital I, Stojadinovic A. Prospective randomized controlled trial comparing standard analgesia with combined intra-operative cystic plate and port-site local anesthesia for post-operative pain management in elective laparoscopic cholecystectomy. Surg Endosc 2016;Epub:Jun 20.

https://www.ncbi.nlm.nih.gov/pubmed/27324337

4 – 208. Teng A, Lee DY, Cai J, Patel SS, Bilchik AJ, Goldfarb MR. Patterns and outcomes of colorectal cancer in adolescents and young adults (AYAs). J Surg Res, In Press.

https://www.ncbi.nlm.nih.gov/pubmed/27620994

2015

1 – Flaherty DC, Deutsch GB, D Kirchoff D, Lee J, Huynh KT, Lee DY, Foshag LJ, Bilchik AJ, Faries MB. Adrenalectomy for Metastatic Melanoma: Current Role in the Age of Nonsurgical Treatments. Am Surg. 2015 Oct;81(10):1005-9.

http://www.ncbi.nlm.nih.gov/pubmed/26463298

2 – Kirchoff DD, Deutsch GB, Fujita M, Lee DY, Sim MS, Lee JH, Bilchik AJ. Overall Survival Is Impacted by Birthplace and Not Extent of Surgery in Asian Americans with Resectable Gastric Cancer. J Gastrointest Surg. 2015 Nov;19(11):1966-73.

http://www.ncbi.nlm.nih.gov/pubmed/26307345

3 – Protic M, Stojadinovic A, Nissan A, Wainberg Z, Steele SR, Chen DC, Avital I, Bilchik AJ. Prognostic Effect of Ultra-Staging Node-Negative Colon Cancer Without Adjuvant Chemotherapy: A Prospective National Cancer Institute-Sponsored Clinical Trial. J Am Coll Surg. 2015 Sep;221(3):643-51; quiz 783-5.

http://www.ncbi.nlm.nih.gov/pubmed/26213360

4 – Lee DY, Flaherty DC, Lau BJ, Deutsch GB, Kirchoff DD, Huynh KT, Lee JH, Faries MB, Bilchik AJ. Attitudes and Perceptions of Surgical Oncology Fellows on ACGME Accreditation and the Complex General Surgical Oncology Certification. Ann Surg Oncol. 2015 Nov;22(12):3776-84.

http://www.ncbi.nlm.nih.gov/pubmed/26122371

5 – Deutsch GB, Lee JH, Bilchik AJ. Long-Term Survival with Long-Acting Somatostatin Analogues Plus Aggressive Cytoreductive Surgery in Patients with Metastatic Neuroendocrine Carcinoma. J Am Coll Surg. 2015 Jul;221(1):26-36.

http://www.ncbi.nlm.nih.gov/pubmed/26027502

6 – Lavotshkin S, Jalas JR, Torisu-Itakura H, Ozao-Choy J, Lee JH, Sim MS, Stojadinovic A, Wainberg Z, Bifulco CB, Fox BA, Bilchik AJ. Immunoprofiling for Prognostic Assessment of Colon Cancer: a Novel Complement to Ultrastaging. J Gastrointest Surg. 2015 Mar 26. [Epub ahead of print]

http://www.ncbi.nlm.nih.gov/pubmed/25808375

7 – Howard JH, Hiles JM, Leung AM, Stern SL, Bilchik AJ. Race influences stage-specific survival in gastric cancer. Am Surg. 2015 Mar;81(3):259-67.

http://www.ncbi.nlm.nih.gov/pubmed/25760201

8 – Huynh KT, Bilchik AJ. Sentinel lymph node biopsy and nodal ultrastaging in colorectal cancer. Cancer J. 2015 Jan-Feb;21(1):11-6.

http://www.ncbi.nlm.nih.gov/pubmed/25611774

9 – Deutsch GB, O’Connor V, Sim MS, Lee JH, Bilchik AJ. Incorporating surgical quality into the AJCC 7th edition improves staging accuracy in gastric cancer. Ann Surg Oncol. 2015 Jan;22(1):11-6.

http://www.ncbi.nlm.nih.gov/pubmed/25192676

10 – Bilchik AJ, Wainberg ZA, Nissan A, Slamon DJ, Protic M, Avital I, Chen HW, Chen D, Sim M, Elashoff D, Stojadinovic A. Value of primary tumor gene signatures in colon cancer when national quality standards are adhered to: preliminary results of an international prospective multicenter trial. Ann Surg Oncol. 2015 Feb;22(2):535-42.

http://www.ncbi.nlm.nih.gov/pubmed/25190115

2014

1 – Deutsch GB, Shamonki J, Bilchik AJ. The cocoon abdomen. JAMA Surg. 2014 Nov;149(11):1201-2.

http://www.ncbi.nlm.nih.gov/pubmed/25208318

2 – Faries MB, Leung A, Morton DL, Hari D, Lee JH, Sim MS, Bilchik AJ. A 20-year experience of hepatic resection for melanoma: is there an expanding role? J Am Coll Surg. 2014 Jul;219(1):62-8.

http://www.ncbi.nlm.nih.gov/pubmed/24952441

3 – Steele SR, Bilchik A, Johnson EK, Nissan A, Peoples GE, Eberhardt JS, Kalina P, Petersen B, Brücher B, Protic M, Avital I, Stojadinovic A. Time-dependent estimates of recurrence and survival in colon cancer: clinical decision support system tool development for adjuvant therapy and oncological outcome assessment. Am Surg. 2014 May;80(5):441-53.

http://www.ncbi.nlm.nih.gov/pubmed/24887722

4 – O’Connor V, Kitagawa Y, Stojadinovic A, Bilchik AJ. Targeted lymph node assessment in gastrointestinal neoplasms. Curr Probl Surg. 2014 Jan;51(1):9-37.

http://www.ncbi.nlm.nih.gov/pubmed/24331086

2013

1 – Leung AM, Hari DM, Howard HJ, Shin-Sim M, Bilchik AJ. Locally advanced hepatocellular carcinoma (Stage IVA): a role for hepatectomy? Am Surg. 2013 Dec;79(12):E343-6.

http://www.ncbi.nlm.nih.gov/pubmed/24351339

2 – Arena EA, Bilchik AJ. What is the optimal means of staging colon cancer? Adv Surg. 2013;47:199-211.

http://www.ncbi.nlm.nih.gov/pubmed/24298852

3 – Hari DM, Leung AM, Lee JH, Sim MS, Vuong B, Chiu CG, Bilchik AJ. AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complexmodifications improve prognostic assessment? J Am Coll Surg. 2013 Aug;217(2):181-90.

http://www.ncbi.nlm.nih.gov/pubmed/23768788

4 – Falch C, Stojadinovic A, Hann-von-Weyhern C, Protic M, Nissan A, Faries MB, Daumer M, Bilchik AJ, Itzhak A, Brücher BL. Anorectal malignant melanoma: extensive 45-year review and proposal for a novel staging classification. J Am Coll Surg. 2013 Aug;217(2):324-35.

http://www.ncbi.nlm.nih.gov/pubmed/23697834

5 – Avital I, Summers TA, Steele SR, Waldman S, Nissan A, Bilchik AJ, Protic M, Man YG, Brücher BL, Stojadinovic A. Colorectal cancer stem cells as biomarkers: where it all starts? J Surg Oncol. 2013 Jun;107(8):791-3.

http://www.ncbi.nlm.nih.gov/pubmed/23512573

6 – Mazeh H, Mizrahi I, Ilyayev N, Halle D, Brücher B, Bilchik A, Protic M, Daumer M, Stojadinovic A, Itzhak A, Nissan A. The Diagnostic and Prognostic Role of microRNA in Colorectal Cancer – a comprehensive review. J Cancer. 2013;4(3):281-95.

http://www.ncbi.nlm.nih.gov/pubmed/23459799

7 – Brücher B, Stojadinovic A, Bilchik A, Protic M, Daumer M, Nissan A, Itzhak A. Patients at risk for peritoneal surface malignancy of colorectal cancer origin: the role of second look laparotomy. J Cancer. 2013;4(3):262-9.

http://www.ncbi.nlm.nih.gov/pubmed/23459716

8 – Summers T, Langan RC, Nissan A, Brücher BL, Bilchik AJ, Protic M, Daumer M, Avital I, Stojadinovic A. Serum-based DNA methylation biomarkers in colorectal cancer: potential for screening and early detection. J Cancer. 2013;4(3):210-6.

http://www.ncbi.nlm.nih.gov/pubmed/23459561

9 – Avital I, Langan RC, Summers TA, Steele SR, Waldman SA, Backman V, Yee J, Nissan A, Young P, Womeldorph C, Mancusco P, Mueller R, Noto K, Grundfest W, Bilchik AJ, Protic M, Daumer M, Eberhardt J, Man YG, Brücher BL, Stojadinovic A. Evidence-based Guidelines for Precision Risk Stratification-Based Screening (PRSBS) for Colorectal Cancer: Lessons learned from the US Armed Forces: Consensus and Future Directions. J Cancer. 2013;4(3):172-92.

http://www.ncbi.nlm.nih.gov/pubmed/23459409

10 – Arciero CA, Henry LR, Howard RS, Peoples GE, Bilchik AJ, Avital I, Buckenmaier Iii CC, Stojadinovic A. Technical effects of adding 1 % lidocaine to technetium sulfur colloid for sentinel lymphatic mapping in early breast cancer: analysis of data from a double-blind randomized controlled trial. Ann Surg Oncol. 2013 Aug;20(8):2548-55.

http://www.ncbi.nlm.nih.gov/pubmed/23443947

11 – Man YG, Stojadinovic A, Mason J, Avital I, Bilchik A, Bruecher B, Protic M, Nissan A, Izadjoo M, Zhang X, Jewett A. Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories. J Cancer. 2013;4(1):84-95.

http://www.ncbi.nlm.nih.gov/pubmed/23386907

12 – Hari DM, Howard JH, Leung AM, Chui CG, Sim MS, Bilchik AJ. A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate? HPB (Oxford). 2013 Jan;15(1):40-8.

http://www.ncbi.nlm.nih.gov/pubmed/23216778

13 – Stojadinovic A, Bilchik A, Smith D, Eberhardt JS, Ward EB, Nissan A, Johnson EK, Protic M, Peoples GE, Avital I, Steele SR. Clinical decision support and individualized prediction of survival in colon cancer: bayesian belief network model. Ann Surg Oncol. 2013 Jan;20(1):161-74.

http://www.ncbi.nlm.nih.gov/pubmed/22899001

2012

1 – Chiu CG, Hari DM, Leung AM, Yoon JL, Sim MS, Bilchik AJ. Are community hospitals meeting the same standards as academic hospitals for the multimodal management of rectal cancer? Am Surg. 2012 Oct;78(10):1172-7.

http://www.ncbi.nlm.nih.gov/pubmed/23189759

2 – Kidner TB, Ozao-Choy JJ, Yoon J, Bilchik AJ. Should quality measures for lymph node dissection in colon cancer be extrapolated to rectal cancer? Am J Surg. 2012 Dec;204(6):843-7; discussion 847-8.

http://www.ncbi.nlm.nih.gov/pubmed/2981183

3 – Brücher BL, Bilchik A, Nissan A, Avital I, Stojadinovic A. Tumor response criteria: are they appropriate? Future Oncol. 2012 Aug;8(8):903-6.

http://www.ncbi.nlm.nih.gov/pubmed/22894663

4 – Nissan A, Protic M, Bilchik AJ, Howard RS, Peoples GE, Stojadinovic A. United States Military Cancer Institute Clinical Trials Group (USMCI GI-01) randomized controlled trial comparing targeted nodal assessment and ultrastaging with standard pathological evaluation for colon cancer. Ann Surg. 2012 Sep;256(3):412-27.

http://www.ncbi.nlm.nih.gov/pubmed/22871988

5 – Stojadinovic A, Nissan A, Wainberg Z, Shen P, McCarter M, Protic M, Howard RS, Steele SR, Peoples GE, Bilchik A. Time-dependent trends in lymph node yield and impact on adjuvant therapy decisions in colon cancer surgery: an international multi-institutional study. Ann Surg Oncol. 2012 Dec;19(13):4178-85.
http://www.ncbi.nlm.nih.gov/pubmed/22805869

6 – Langan RC, Mullinax JE, Ray S, Raiji MT, Schaub N, Xin HW, Koizumi T, Steinberg SM, Anderson A, Wiegand G, Butcher D, Anver M, Bilchik AJ, Stojadinovic A, Rudloff U, Avital I. A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers. J Cancer. 2012;3:231-40.

http://www.ncbi.nlm.nih.gov/pubmed/23459666

7 – Eberhardt J, Bilchik A, Stojadinovic A. Clinical decision support systems: potential with pitfalls. J Surg Oncol. 2012 Apr 1;105(5):502-10.

http://www.ncbi.nlm.nih.gov/pubmed/22441903

8 – Short SS, Stojadinovic A, Nissan A, Wainberg Z, Dhall D, Yao K, Bilchik A. Adjuvant treatment of early colon cancer with micrometastases: results of a national survey. J Surg Oncol. 2012 Aug 1;106(2):119-22.

http://www.ncbi.nlm.nih.gov/pubmed/22308106

9 – Hari DM, Bilchik AJ. Clinical decision-making and implementation challenges with the AJCC VII staging system for colorectal carcinoma. J Surg Oncol. 2012 Mar;105(3):221-2.
http://www.ncbi.nlm.nih.gov/pubmed/22271497

10 – Steele S, Bilchik A, Eberhardt J, Kalina P, Nissan A, Johnson E, Avital I, Stojadinovic A. Using machine-learned bayesian belief networks to predict perioperative risk of clostridium difficile infection following colon surgery. Interact J Med Res. 2012 Sep 19;1(2):e6.
http://www.ncbi.nlm.nih.gov/pubmed/23611947

2011

1 – Diverting ileostomies: primum minus nocere (first, do less harm).
Bilchik A, Faries MB.Arch Surg. 2011 Oct;146(10):1196-7. No abstract available.

2 – The impact of age on quality measure adherence in colon cancer.
Steele SR, Chen SL, Stojadinovic A, Nissan A, Zhu K, Peoples GE, Bilchik A.J Am Coll Surg. 2011 Jul;213(1):95-103; discussion 104-5. doi: 10.1016/j.jamcollsurg.2011.04.013. Epub 2011 May 20.

3 – Comparison of nodal positivity between SLNM vs conventional surgery in colon cancer patients with lymph nodes harvested
Soni M, Wiese D, Korant A, Sirop S, Chakravarty B, Gayar A, Bilchik A, Beutler T, Ratz D, Saha S. Am J Surg. 2011 Aug;202(2):207-13. doi: 10.1016/j.amjsurg.2010.06.028. Epub 2011 Feb 1.

4 – Lymph node ratio as a quality and prognostic indicator in stage III colon cancer.
Chen SL, Steele SR, Eberhardt J, Zhu K, Bilchik A, Stojadinovic A. Ann Surg. 2011 Jan;253(1):82-7. doi: 10.1097/SLA.0b013e3181ffa780.

2010

1 – Is it time to move beyond lymph node evaluation in the staging of colon cancer?
Bilchik A, Stojadinovic A. Arch Surg. 2010 Sep;145(9):830-1. No abstract available.

2 – Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials.
Bilchik A, Nissan A, Wainberg Z, Shen P, McCarter M, Protic M, Howard R, Elashoff D, Tyler J, Peoples GE, Stojadinovic A.
Ann Surg. 2010 Sep;252(3):467-74; discussion 474-6. doi: 10.1097/SLA.0b013e3181f19767.

3 – Predictors of occult nodal metastasis in colon cancer: results from a prospective multicenter trial.
Wasif N, Faries MB, Saha S, Turner RR, Wiese D, McCarter MD, Shen P, Stojadinovic A, Bilchik AJ.
Surgery. 2010 Mar;147(3):352-7. doi: 10.1016/j.surg.2009.10.008. Epub 2010 Feb 8.

4 – Predictive model of outcome of targeted nodal assessment in colorectal cancer.
Nissan A, Protic M, Bilchik A, Eberhardt J, Peoples GE, Stojadinovic A.
Ann Surg. 2010 Feb;251(2):265-74. doi: 10.1097/SLA.0b013e3181bd5187.

2009

1 – Sentinel node biopsy for the individualization of surgical strategy for cure of early-stage colon cancer.
Cahill RA, Bembenek A, Sirop S, Waterhouse DF, Schneider W, Leroy J, Wiese D, Beutler T, Bilchik A, Saha S, Schlag PM.
Ann Surg Oncol. 2009 Aug;16(8):2170-80. doi: 10.1245/s10434-009-0510-9. Epub 2009 May 27.

2 – Targeted lymph node evaluation in colorectal cancer: a decade of progress!
Bilchik AJ, Stojadinovic A, Wainberg Z, Hecht JR.
J Surg Oncol. 2009 Apr 1;99(5):273-4. doi: 10.1002/jso.21231. No abstract available.

2008

1 – Focal nodular hyperplasia: report of an unusual case and review of the literature.
Wasif N, Sasu S, Conway WC, Bilchik A.
Am Surg. 2008 Nov;74(11):1100-3. Review.

2 – Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial.
Koyanagi K, Bilchik AJ, Saha S, Turner RR, Wiese D, McCarter M, Shen P, Deacon L, Elashoff D, Hoon DS.
Clin Cancer Res. 2008 Nov 15;14(22):7391-6. doi: 10.1158/1078-0432.CCR-08-0290.

3 – Prognostic variables for resection of colorectal cancer hepatic metastases: an evolving paradigm.
Bilchik AJ, Poston G, Adam R, Choti MA.
J Clin Oncol. 2008 Nov 20;26(33):5320-1. doi: 10.1200/JCO.2008.18.3152. Epub 2008 Oct 20. No abstract available.

4 – Urgent need for a new staging system in advanced colorectal cancer.
Poston GJ, Figueras J, Giuliante F, Nuzzo G, Sobrero AF, Gigot JF, Nordlinger B, Adam R, Gruenberger T, Choti MA, Bilchik AJ, Van Cutsem EJ, Chiang JM, D’Angelica MI.
J Clin Oncol. 2008 Oct 10;26(29):4828-33. doi: 10.1200/JCO.2008.17.6453. Epub 2008 Aug 18.

5 – Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence.
de Maat MF, van de Velde CJ, van der Werff MP, Putter H, Umetani N, Klein-Kranenbarg EM, Turner RR, van Krieken JH, Bilchik A, Tollenaar RA, Hoon DS.
J Clin Oncol. 2008 May 10;26(14):2327-35. doi: 10.1200/JCO.2007.14.0723.

6 – Perioperative risks of bevacizumab and other biologic agents for hepatectomy: theoretical or evidence based?
Bilchik AJ, Hecht JR.
J Clin Oncol. 2008 Apr 10;26(11):1786-8. doi: 10.1200/JCO.2007.15.6380. No abstract available.

7 – Significance of the lymph node ratio in stage III colon cancer.
Telian SH, Bilchik AJ.
Ann Surg Oncol. 2008 Jun;15(6):1557-8. doi: 10.1245/s10434-008-9862-9. Epub 2008 Mar 25. No abstract available.

8 – A rare cause of primary hepatic neoplasm: malignant peripheral nerve sheath tumor in the age of modern liver surgery.
Iddings DM, Wright BE, Bilchik A.
Am Surg. 2008 Jan;74(1):47-50.

9 – The biologic significance of micrometastatic disease and sentinel lymph node technology on colorectal cancer.
Iddings D, Bilchik A.
J Surg Oncol. 2007 Dec 15;96(8):671-7. Review.

10 – Thermal ablation of hepatic malignancy: useful but still not optimal.
Nicholl MB, Bilchik AJ.
Eur J Surg Oncol. 2008 Mar;34(3):318-23. Epub 2007 Dec 4.

11 – Is routine use of sentinel node biopsy justified in colon cancer?
Nicholl M, Bilchik AJ.
Ann Surg Oncol. 2008 Jan;15(1):1-3. Epub 2007 Oct 11. No abstract available.

2007

1 – Current and emerging trends in the treatment of early-stage colorectal cancer: importance of a multidisciplinary approach.
Bilchik AJ.
Hematol Oncol Clin North Am. 2007 Feb;21 Suppl 1:8-18. Review. No abstract available.

2 – New approaches to assessing and treating early-stage colon and rectal cancer: summary statement from 2007 Santa Monica Conference.
Rosen LS, Bilchik AJ, Beart RW Jr, Benson AB 3rd, Chang KJ, Compton CC, Grothey A, Haller DG, Ko CY, Lynch PM, Nelson H, Stamos MJ, Turner RR, Willett CG.
Clin Cancer Res. 2007 Nov 15;13(22 Pt 2):6853s-6s.

3 – Management of T2 gallbladder cancer: are practice patterns consistent with national recommendations?
Wright BE, Lee CC, Iddings DM, Kavanagh M, Bilchik AJ.
Am J Surg. 2007 Dec;194(6):820-5; discussion 825-6.

4 – Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer.
de Maat MF, van de Velde CJ, Umetani N, de Heer P, Putter H, van Hoesel AQ, Meijer GA, van Grieken NC, Kuppen PJ, Bilchik AJ, Tollenaar RA, Hoon DS.
J Clin Oncol. 2007 Nov 1;25(31):4887-94.

5 – Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.
Bilchik AJ, Hoon DS, Saha S, Turner RR, Wiese D, DiNome M, Koyanagi K, McCarter M, Shen P, Iddings D, Chen SL, Gonzalez M, Elashoff D, Morton DL.
Ann Surg. 2007 Oct;246(4):568-75; discussion 575-7.

6 – Image of the month. Serrated Adenomatous Polyposis.
Kavanagh MA, Ahmad A, Amadpour M, Bilchik AJ.
Arch Surg. 2007 Sep;142(9):901-2. No abstract available.

7 – Association of angiogenesis markers with lymph node metastasis in early colorectal cancer.
Iddings DM, Koda EA, Grewal SS, Parker R, Saha S, Bilchik A.
Arch Surg. 2007 Aug;142(8):738-44; discussion 744-5.

8 – Hepatic cytoreductive surgery for neuroendocrine cancer.
Wright BE, Lee CC, Bilchik AJ.
Surg Oncol Clin N Am. 2007 Jul;16(3):627-37, ix-x. Review.

9 – Role of repeated hepatectomy in the multimodal treatment of hepatic colorectal metastases.
Ahmad A, Chen SL, Bilchik AJ.
Arch Surg. 2007 Jun;142(6):526-31; discussion 531-2.

10 – Resecting lymph nodes in colon cancer: more than a staging operation?
Chen SL, Bilchik AJ.
Ann Surg Oncol. 2007 Aug;14(8):2175-6. Epub 2007 May 25. No abstract available. Erratum in: Ann Surg Oncol. 2011 Dec;18 Suppl 3:S336.

11 – Close collaboration between surgeon and pathologist is essential for accurate staging of early colon cancer.
Bilchik AJ, Compton C.
Ann Surg. 2007 Jun;245(6):864-6. No abstract available.

12 – Gastric carcinoma: applying the sentinel node paradigm to improve the understanding of metastatic patterns and the possible role of selective lymphadenectomy.
Iddings DM, Bilchik A.
Ann Surg Oncol. 2007 Sep;14(9):2432-4. Epub 2007 May 23. No abstract available.

2006

1 – Treatment disparities in Hispanic rectal cancer patients: a SEER database study.
Martinez SR, Chen SL, Bilchik AJ.
Am Surg. 2006 Oct;72(10):906-8.

2 – Radiofrequency ablation of hepatic metastases from colorectal cancer: are newer generation probes better?
Ahmad A, Chen SL, Kavanagh MA, Allegra DP, Bilchik AJ.
Am Surg. 2006 Oct;72(10):875-9.

3 – The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis.
Iddings D, Ahmad A, Elashoff D, Bilchik A.
Ann Surg Oncol. 2006 Nov;13(11):1386-92. Epub 2006 Sep 29.

4 – Lymphatic mapping and sentinel node analysis: current concepts and applications.
Chen SL, Iddings DM, Scheri RP, Bilchik AJ.
CA Cancer J Clin. 2006 Sep-Oct;56(5):292-309; quiz 316-7. Review.

5 – More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study.
Chen SL, Bilchik AJ.
Ann Surg. 2006 Oct;244(4):602-10.

6 – Improving resectability of hepatic colorectal metastases: expert consensus statement.
Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D.
Ann Surg Oncol. 2006 Oct;13(10):1271-80. Epub 2006 Sep 6. No abstract available.

7 – Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome.
Kim J, Mori T, Chen SL, Amersi FF, Martinez SR, Kuo C, Turner RR, Ye X, Bilchik AJ, Morton DL, Hoon DS.
Ann Surg. 2006 Jul;244(1):113-20.

8 – Long-term survival after radiofrequency ablation of complex unresectable liver tumors.
Amersi FF, McElrath-Garza A, Ahmad A, Zogakis T, Allegra DP, Krasne R, Bilchik AJ.
Arch Surg. 2006 Jun;141(6):581-7; discussion 587-8.

9 – Prospective multicenter trial of staging adequacy in colon cancer: preliminary results.
Bilchik AJ, DiNome M, Saha S, Turner RR, Wiese D, McCarter M, Hoon DS, Morton DL.
Arch Surg. 2006 Jun;141(6):527-33; discussion 533-4.

10 – Sentinel lymph node mapping with GI cancer.
Aikou T, Kitagawa Y, Kitajima M, Uenosono Y, Bilchik AJ, Martinez SR, Saha S.
Cancer Metastasis Rev. 2006 Jun;25(2):269-77. Review.

11 – Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats.
Umetani N, Kim J, Hiramatsu S, Reber HA, Hines OJ, Bilchik AJ, Hoon DS.
Clin Chem. 2006 Jun;52(6):1062-9.

12 – Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins.
Kim J, Reber HA, Dry SM, Elashoff D, Chen SL, Umetani N, Kitago M, Hines OJ, Kazanjian KK, Hiramatsu S, Bilchik AJ, Yong S, Shoup M, Hoon DS.
Gut. 2006 Nov;55(11):1598-605. Epub 2006 May 8. Erratum in: Gut. 2006 Dec;55(12):1824.

13 – Colorectal cancer screening and surveillance: current standards and future trends.
Martinez SR, Young SE, Hoedema RE, Foshag LJ, Bilchik AJ.
Ann Surg Oncol. 2006 Jun;13(6):768-75. Epub 2006 Apr 12. Review.

14 – A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence.
Saha S, Sehgal R, Patel M, Doan K, Dan A, Bilchik A, Beutler T, Wiese D, Bassily N, Yee C.
Am J Surg. 2006 Mar;191(3):305-10. Erratum in: Am J Surg. 2009 Jul;198(1):156. Seghal, Rajesh [corrected to Sehgal, Rajesh].

15 – The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases.
Martinez SR, Young SE, Giuliano AE, Bilchik AJ.
Am J Surg. 2006 Feb;191(2):281-3.

16 – Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note.
Bilchik AJ, Poston G, Curley SA, Strasberg S, Saltz L, Adam R, Nordlinger B, Rougier P, Rosen LS.
J Clin Oncol. 2005 Dec 20;23(36):9073-8. No abstract available. Erratum in: J Clin Oncol. 2006 Apr 1;24(10):1648.

17 – The clinical significance of MAGEA3 expression in pancreatic cancer.
Kim J, Reber HA, Hines OJ, Kazanjian KK, Tran A, Ye X, Amersi FF, Martinez SR, Dry SM, Bilchik AJ, Hoon DS.
Int J Cancer. 2006 May 1;118(9):2269-75.

2005

1 – X-Linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling.
Takeuchi H, Kim J, Fujimoto A, Umetani N, Mori T, Bilchik A, Turner R, Tran A, Kuo C, Hoon DS.
Clin Cancer Res. 2005 Nov 1;11(21):7621-8.

2 – Preoperative serum TA90-IC as an adjunct to serum CA 19-9 in the diagnosis of pancreatic malignancy: a pilot study.
Chung MH, Gupta RK, Bilchik AJ, Ye W, Yee R, Morton DL.
Curr Surg. 2002 Mar-Apr;59(2):194-8.

3 – Quality control issues in the management of colon cancer patients.
Martinez SR, Bilchik AJ.
Eur J Surg Oncol. 2005 Aug;31(6):616-29. Review.

4 – Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C, Foshag L, Bilchik AJ, Hoon DS.
J Clin Oncol. 2005 Apr 20;23(12):2744-53.

5 – Lymphatic mapping and sentinel node analysis in colon cancer.
Martinez SR, Bilchik AJ.
Clin Colorectal Cancer. 2005 Jan;4(5):320-4. Review.

2004

1 – Comparative analysis of nodal upstaging between colon and rectal cancers by sentinel lymph node mapping: a prospective trial.
Saha S, Monson KM, Bilchik A, Beutler T, Dan AG, Schochet E, Wiese D, Kaushal S, Ganatra B, Desai D.
Dis Colon Rectum. 2004 Nov;47(11):1767-72.

2 – Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
Umetani N, Takeuchi H, Fujimoto A, Shinozaki M, Bilchik AJ, Hoon DS.
Clin Cancer Res. 2004 Nov 15;10(22):7475-83.

3 – Allelic imbalance of APAF-1 locus at 12q23 is related to progression of colorectal carcinoma.
Umetani N, Fujimoto A, Takeuchi H, Shinozaki M, Bilchik AJ, Hoon DS.
Oncogene. 2004 Oct 28;23(50):8292-300.

4 – Peptide nucleic acid clamp PCR: a novel K-ras mutation detection assay for colorectal cancer micrometastases in lymph nodes.
Taback B, Bilchik AJ, Saha S, Nakayama T, Wiese DA, Turner RR, Kuo CT, Hoon DS.
Int J Cancer. 2004 Sep 1;111(3):409-14.

5 – Novel effective drugs and evolving ablation technology: a more comprehensive approach to hepatic malignancies.
Bilchik AJ, Martinez SR.
Ann Surg Oncol. 2004 May;11(5):458-9. Epub 2004 Apr 12. No abstract available.

6 – Historical review of lymphatic mapping in gastrointestinal malignancies.
Saha S, Dan AG, Bilchik AJ, Kitagawa Y, Schochet E, Choudhri S, Saha LT, Wiese D, Morton D, Kitajima M.
Ann Surg Oncol. 2004 Mar;11(3 Suppl):245S-9S. Review.

2003

1 – Radiofrequency ablation of hepatic malignancies: inexpensive and minimally invasive but should it replace resection?
Bilchik AJ, Faries M.
Ann Surg Oncol. 2003 Nov;10(9):1002-4. No abstract available.

2 – Differential expression of thymidylate synthase in colorectal tumors and matched lymph nodes: impact on adjuvant treatment.
Trocha SD, Saha SS, Wiese D, Thompson J, Morton DL, Bilchik AJ.
Am Surg. 2003 Oct;69(10):918-22.

3 – Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases.
Morton DL, Hoon DS, Cochran AJ, Turner RR, Essner R, Takeuchi H, Wanek LA, Glass E, Foshag LJ, Hsueh EC, Bilchik AJ, Elashoff D, Elashoff R.
Ann Surg. 2003 Oct;238(4):538-49; discussion 549-50.

4 – Lymphatic mapping and sentinel node analysis to optimize laparoscopic resection and staging of colorectal cancer: an update.
Bilchik AJ, Trocha SD.
Cancer Control. 2003 May-Jun;10(3):219-23.

5 – Colorectal carcinoma nodal staging. Frequency and nature of cytokeratin-positive cells in sentinel and nonsentinel lymph nodes.
Turner RR, Nora DT, Trocha SD, Bilchik AJ.
Arch Pathol Lab Med. 2003 Jun;127(6):673-9.

6 – Arterial chemotherapy as adjuvant and palliative treatment of hepatic colorectal metastases: an update.
Bilchik AJ.
Surg Oncol Clin N Am. 2003 Jan;12(1):193-210. Review.

7 – c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases.
Takeuchi H, Bilchik A, Saha S, Turner R, Wiese D, Tanaka M, Kuo C, Wang HJ, Hoon DS.
Clin Cancer Res. 2003 Apr;9(4):1480-8.

8 – More (nodes) + more (analysis) = less (mortality): challenging the therapeutic equation for early-stage colon cancer.
Bilchik A.
Ann Surg Oncol. 2003 Apr;10(3):203-5. No abstract available.

9 – Combination probe and dye-directed lymphatic mapping detects micrometastases in early colorectal cancer.
Trocha SD, Nora DT, Saha SS, Morton DL, Wiese D, Bilchik AJ.
J Gastrointest Surg. 2003 Mar-Apr;7(3):340-5; discussion 345-6.

10 – Effect of lymphatic mapping on the new tumor-node-metastasis classification for colorectal cancer.
Bilchik AJ, Nora DT, Sobin LH, Turner RR, Trocha S, Krasne D, Morton DL.
J Clin Oncol. 2003 Feb 15;21(4):668-72.

11 – Modulators of ceramide metabolism sensitize colorectal cancer cells to chemotherapy: a novel treatment strategy.
Litvak DA, Bilchik AJ, Cabot MC.
J Gastrointest Surg. 2003 Jan;7(1):140-8; discussion 148.

12 – Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned.
Bleicher RJ, Allegra DP, Nora DT, Wood TF, Foshag LJ, Bilchik AJ.
Ann Surg Oncol. 2003 Jan-Feb;10(1):52-8.

2002

1 – The use of molecular profiling of early colorectal cancer to predict micrometastases.
Bilchik AJ, Nora DT, Saha S, Turner R, Wiese D, Kuo C, Ye X, Morton DL, Hoon DS.
Arch Surg. 2002 Dec;137(12):1377-83.

2 – Cryosurgical ablation of liver tumors in colon cancer patients increases the serum total ganglioside level and then selectively augments antiganglioside IgM.
Ravindranath MH, Wood TF, Soh D, Gonzales A, Muthugounder S, Perez C, Morton DL, Bilchik AJ.
Cryobiology. 2002 Aug;45(1):10-21.

3 – Systemic irinotecan or regional floxuridine chemotherapy prolongs survival after hepatic cryosurgery in patients with metastatic colon cancer refractory to 5-fluorouracil.
Bilchik AJ, Wood TF, Chawla SP, Rose DM, Chung MH, Stern SS, Foshag LJ, Ramming KP.
Clin Colorectal Cancer. 2001 May;1(1):36-42.

4 – Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodes.
Morton DL, Hsueh EC, Essner R, Foshag LJ, O’Day SJ, Bilchik A, Gupta RK, Hoon DS, Ravindranath M, Nizze JA, Gammon G, Wanek LA, Wang HJ, Elashoff RM.
Ann Surg. 2002 Oct;236(4):438-48; discussion 448-9.

5 – A novel lymphatic mapping technique to improve localization and staging of early colon cancer during laparoscopic colectomy.
Tsioulias GJ, Wood TF, Spirt M, Morton DL, Bilchik AJ.
Am Surg. 2002 Jul;68(7):561-5.

6 – Lymphatic mapping of nodal micrometastasis in colon cancer: putting the cart before the horse?
Bilchik AJ, Nora DT.
Ann Surg Oncol. 2002 Jul;9(6):529-31. No abstract available.

7 – One hundred consecutive cases of sentinel lymph node mapping in early colorectal carcinoma: detection of missed micrometastases.
Wood TF, Nora DT, Morton DL, Turner RR, Rangel D, Hutchinson W, Bilchik AJ.
J Gastrointest Surg. 2002 May-Jun;6(3):322-9; discussion 229-30.

8 – Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis.
Bilchik AJ, Nora D, Tollenaar RA, van de Velde CJ, Wood T, Turner R, Morton DL, Hoon DS.
Eur J Cancer. 2002 May;38(7):977-85.

9 – Serum total gangliosides and TA90-IC levels: novel immunologic markers in colorectal cancer.
Perez CA, Ravindranath MH, Gupta RK, Tollenaar RA, van de Velde CJ, Wood TF, Soh D, Morton DL, Bilchik AJ.
Cancer J. 2002 Jan-Feb;8(1):55-61.

10 – Systemic irinotecan and regional floxuridine after hepatic cytoreduction in 185 patients with unresectable colorectal cancer metastases.
Litvak DA, Wood TF, Tsioulias GJ, Chung M, Chawla SP, Foshag LJ, Morton DL, Ramming KP, Bilchik AJ.
Ann Surg Oncol. 2002 Mar;9(2):148-55.

2001

1 – Solid and papillary epithelial neoplasms of the pancreas: aggressive resection for cure.
Yoon DY, Hines OJ, Bilchik AJ, Lewin K, Cortina G, Reber HA.
Am Surg. 2001 Dec;67(12):1195-9.

2 – Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver.
Chung MH, Pisegna J, Spirt M, Giuliano AE, Ye W, Ramming KP, Bilchik AJ.
Surgery. 2001 Dec;130(6):954-62.

3 – Ultrastaging of colorectal cancer by sentinel lymph node mapping technique–a multicenter trial.
Saha S, Bilchik A, Wiese D, Espinosa M, Badin J, Ganatra BK, Desai D, Kaushal S, Singh T, Arora M.
Ann Surg Oncol. 2001 Oct;8(9 Suppl):94S-98S.

4 – Aberrant drainage and missed micrometastases: the value of lymphatic mapping and focused analysis of sentinel lymph nodes in gastrointestinal neoplasms.
Bilchik AJ, Saha S, Tsioulias GJ, Wood TF, Morton DL.
Ann Surg Oncol. 2001 Oct;8(9 Suppl):82S-85S.

5 – Lymphatic mapping improves staging during laparoscopic colectomy for cancer.
Wood TF, Spirt M, Rangel D, Shen P, Tsioulias GJ, Morton DL, Bilchik AJ.
Surg Endosc. 2001 Jul;15(7):715-9. Epub 2001 May 2.

6 – Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience.
Rose DM, Essner R, Hughes TM, Tang PC, Bilchik A, Wanek LA, Thompson JF, Morton DL.
Arch Surg. 2001 Aug;136(8):950-5.

7 – Laparoscopic radiofrequency ablation of unresectable hepatic malignancies. A phase 2 trial.
Chung MH, Wood TF, Tsioulias GJ, Rose DM, Bilchik AJ.
Surg Endosc. 2001 Sep;15(9):1020-6. Epub 2001 Jun 12.

8 – Diagnostic laparoscopy and laparoscopic ultrasonography optimize the staging and resectability of intraabdominal neoplasms.
Tsioulias GJ, Wood TF, Chung MH, Morton DL, Bilchik A.
Surg Endosc. 2001 Sep;15(9):1016-9. Epub 2001 Jun 12.

9 – CancerVax, an allogeneic tumor cell vaccine, induces specific humoral and cellular immune responses in advanced colon cancer.
Habal N, Gupta RK, Bilchik AJ, Yee R, Leopoldo Z, Ye W, Elashoff RM, Morton DL.
Ann Surg Oncol. 2001 Jun;8(5):389-401.

10 – Repeat hepatic cryotherapy for metastatic colorectal cancer.
Chung MH, Ye W, Ramming KP, Bilchik AJ.
J Gastrointest Surg. 2001 May-Jun;5(3):287-93.

11 – Interleukin-2 binds to ganglioside GD(1b).
Ravindranath MH, Gonzales A, Soh D, Nishimoto K, Tam WY, Bilchik A, Morton DL, O’Day S.
Biochem Biophys Res Commun. 2001 May 4;283(2):369-73.

12 – Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques.
Wood TF, Saha S, Morton DL, Tsioulias GJ, Rangel D, Hutchinson W Jr, Foshag LJ, Bilchik AJ.
Ann Surg Oncol. 2001 Mar;8(2):150-7.

13 – Molecular strategy for detecting metastatic cancers with use of multiple tumor-specific MAGE-A genes.
Miyashiro I, Kuo C, Huynh K, Iida A, Morton D, Bilchik A, Giuliano A, Hoon DS.
Clin Chem. 2001 Mar;47(3):505-12.

14 – Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial.
Bilchik AJ, Saha S, Wiese D, Stonecypher JA, Wood TF, Sostrin S, Turner RR, Wang HJ, Morton DL, Hoon DS.
J Clin Oncol. 2001 Feb 15;19(4):1128-36. Erratum in: J Clin Oncol 2001 May 1;19(9):2583.

15 – Radiofrequency ablation of unresectable hepatic malignancies: lessons learned.
Bilchik AJ, Wood TF, Allegra DP.
Oncologist. 2001;6(1):24-33.

2000

1 – Gastrointestinal carcinoid tumors and second primary malignancies.
Habal N, Sims C, Bilchik AJ.
J Surg Oncol. 2000 Dec;75(4):310-6. Review.

2 – Focused examination of sentinel lymph nodes upstages early colorectal carcinoma.
Wood TF, Tsioulias GJ, Morton DL, Rangel D, Hutchinson W Jr, Foshag LJ, Turner RR, Bilchik AJ.
Am Surg. 2000 Nov;66(11):998-1003.

3 – Does human melanoma express carcinoembryonic antigen?
Ravindranath MH, Shen P, Habal N, Soh D, Nishimoto K, Gonzales A, Tam WY, Bilchik A, Morton DL.
Anticancer Res. 2000 Sep-Oct;20(5A):3083-92.

4 – Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications.
Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ.
Ann Surg Oncol. 2000 Sep;7(8):593-600.

5 – Lymphatic mapping and focused analysis of sentinel lymph nodes upstage gastrointestinal neoplasms.
Tsioulias GJ, Wood TF, Morton DL, Bilchik AJ.
Arch Surg. 2000 Aug;135(8):926-32.

6 – TA90-IC, a new marker for advanced colon cancer.
Habal N, Gupta RK, Bilchik AJ, Johnson T, Morton DL.
Ann Surg Oncol. 2000 Jun;7(5):352-6.

7 – Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm.
Bilchik AJ, Wood TF, Allegra D, Tsioulias GJ, Chung M, Rose DM, Ramming KP, Morton DL.
Arch Surg. 2000 Jun;135(6):657-62; discussion 662-4.

8 – Gangliosides as targets for immunotherapy for pancreatic adenocarcinoma.
Chu KU, Ravindranath MH, Gonzales A, Nishimoto K, Tam WY, Soh D, Bilchik A, Katopodis N, Morton DL.
Cancer. 2000 Apr 15;88(8):1828-36.

9 – Molecular detection of metastatic pancreatic carcinoma cells using a multimarker reverse transcriptase-polymerase chain reaction assay.
Bilchik A, Miyashiro M, Kelley M, Kuo C, Fujiwara Y, Nakamori S, Monden M, Hoon DS.
Cancer. 2000 Mar 1;88(5):1037-44.

10 – Role of Na+-glucose cotransport in jejunal meal-induced absorption.
Hines OJ, Whang EE, Bilchik AJ, Zinner MJ, Welton ML, Lane J, McFadden DW, Ashley SW.
Dig Dis Sci. 2000 Jan;45(1):1-6.

1999

1 – Radiofrequency ablation: a minimally invasive technique with multiple applications.
Bilchik AJ, Rose DM, Allegra DP, Bostick PJ, Hsueh E, Morton DL.
Cancer J Sci Am. 1999 Nov-Dec;5(6):356-61.

2 – Radiofrequency ablation: a novel primary and adjunctive ablative technique for hepatic malignancies.
Rose DM, Allegra DP, Bostick PJ, Foshag LJ, Bilchik AJ.
Am Surg. 1999 Nov;65(11):1009-14.

3 – Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?
Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A, Giuliano AE.
Ann Surg. 1999 Apr;229(4):536-41.

1998

1 – Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms.
Bilchik AJ, Giuliano A, Essner R, Bostick P, Kelemen P, Foshag LJ, Sostrin S, Turner RR, Morton DL.
Cancer J Sci Am. 1998 Nov-Dec;4(6):351-8.

2 – Complications of hepatic cryosurgery.
Sarantou T, Bilchik A, Ramming KP.
Semin Surg Oncol. 1998 Mar;14(2):156-62. Review.

1997

1 – Cryosurgical palliation of metastatic neuroendocrine tumors resistant to conventional therapy.
Bilchik AJ, Sarantou T, Foshag LJ, Giuliano AE, Ramming KP.
Surgery. 1997 Dec;122(6):1040-7; discussion 1047-8.

2 – Cryosurgery causes a profound reduction in tumor markers in hepatoma and noncolorectal hepatic metastases.
Bilchik AJ, Sarantou T, Wardlaw JC, Ramming KP.
Am Surg. 1997 Sep;63(9):796-800.

3 – Antisecretory mechanisms of peptide YY in rat distal colon.
Whang EE, Hines OJ, Reeve JR Jr, Grandt D, Moser JA, Bilchik AJ, Zinner MJ, McFadden DW, Ashley SW.
Dig Dis Sci. 1997 Jun;42(6):1121-7.

1996

1 – Peptide YY: a potential proabsorptive hormone for the treatment of malabsorptive disorders.
Liu CD, Aloia T, Adrian TE, Newton TR, Bilchik AJ, Zinner MJ, Ashley SW, McFadden DW.
Am Surg. 1996 Mar;62(3):232-6.

1995

1 – Na+/H+ exchange mediates postprandial ileal water and electrolyte transport.
Hines OJ, Bilchik AJ, McFadden DW, Rodgers PJ, Bautista N, Zinner MJ, Ashley SW.
Dig Dis Sci. 1995 Apr;40(4):774-80.

2 – Early regional expression and secretion of peptide YY and enteroglucagon after massive resection of small bowel.
Bilchik AJ, Hines OJ, Adrian TE, Skotzko MJ, McFadden DW, Zinner MJ, Ashley SW.
J Am Coll Surg. 1995 Apr;180(4):417-26.

3 – Amino acids mediate postprandial jejunal proabsorption.
Hines OJ, Bilchik AJ, Ashley SW, Whang EE, Liu CD, Zinner MJ, McFadden DW.
J Surg Res. 1995 Jan;58(1):81-5.

1994

1 – Peptide YY immunoneutralization inhibits meal-induced absorption in vivo.
Bilchik AJ, Hines OJ, Ashley SW, Adrian TE, Walsh J, Wong H, Liu CD, Zinner MJ, McFadden DW.
Surgery. 1994 Dec;116(6):1153-7; discussion 1157-8.

2 – Up-regulation of Na+,K+ adenosine triphosphatase after massive intestinal resection.
Hines OJ, Bilchik AJ, McFadden DW, Skotzko MJ, Whang EE, Zinner MJ, Ashley SW.
Surgery. 1994 Aug;116(2):401-7; discussion 408.

3 – Effects of raw soya diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster.
Herrington MK, Permert J, Kazakoff KR, Zucker KA, Bilchik AJ, Pour PM, Adrian TE.
Cancer Lett. 1994 Jul 15;82(1):7-16.

4 – Adaptation of the Na+/glucose cotransporter following intestinal resection.
Hines OJ, Bilchik AJ, Zinner MJ, Skotzko MJ, Moser AJ, McFadden DW, Ashley SW.
J Surg Res. 1994 Jul;57(1):22-7.

5 – Peptide YY augments postprandial small intestinal absorption in the conscious dog.
Bilchik AJ, Hines OJ, Zinner MJ, Adrian TE, Berger JJ, Ashley SW, McFadden DW.
Am J Surg. 1994 Jun;167(6):570-4.

1993

1 – Peptide YY is a physiological regulator of water and electrolyte absorption in the canine small bowel in vivo.
Bilchik AJ, Hines OJ, Adrian TE, McFadden DW, Berger JJ, Zinner MJ, Ashley SW.
Gastroenterology. 1993 Nov;105(5):1441-8.

2 – Cyclic AMP-mediated release of peptide YY (PYY) from the isolated perfused rabbit distal colon.
Ballantyne GH, Goldenring JR, Savoca PE, Kranz HK, Adrian TE, Bilchik AJ, Modlin IM.
Regul Pept. 1993 Sep 3;47(2):117-26.

3 – Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon.
Adrian TE, Ballantyne GH, Longo WE, Bilchik AJ, Graham S, Basson MD, Tierney RP, Modlin IM.
Gut. 1993 Sep;34(9):1219-24.

4 – Management of unresectable malignant endocrine tumors of the pancreas.
Modlin IM, Lewis JJ, Ahlman H, Bilchik AJ, Kumar RR.
Surg Gynecol Obstet. 1993 May;176(5):507-18. Review.

5 – Effects of high fat diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster.
Herrington MK, Permert J, Kazakoff KR, Pour PM, Zuker KA, Bilchik AJ, Adrian TE.
Carcinogenesis. 1993 May;14(5):1021-6.

6 – Influence of chloroquine on diet-induced pancreatitis.
Leach SD, Bilchik AJ, Karapetian O, Gorelick FS, Modlin IM.
Pancreas. 1993 Jan;8(1):64-9.

1992

1 – Plasma and tissue alterations of peptide YY and enteroglucagon in rats after colectomy.
Vukasin AP, Ballantyne GH, Nilsson O, Bilchik AJ, Adrian TE, Modlin IM.
Yale J Biol Med. 1992 Jan-Feb;65(1):1-15.

1991

1 – Distribution and immunocytochemical colocalization of peptide YY and enteroglucagon in endocrine cells of the rabbit colon.
Nilsson O, Bilchik AJ, Goldenring JR, Ballantyne GH, Adrian TE, Modlin IM.
Endocrinology. 1991 Jul;129(1):139-48.

2 – Short-chain fatty acid release of peptide YY in the isolated rabbit distal colon.
Longo WE, Ballantyne GH, Savoca PE, Adrian TE, Bilchik AJ, Modlin IM.
Scand J Gastroenterol. 1991 Apr;26(4):442-8.

3 – Adaptive increase in peptide YY and enteroglucagon after proctocolectomy and pelvic ileal reservoir construction.
Armstrong DN, Ballantyne GH, Adrian TE, Bilchik AJ, McMillen MA, Modlin IM.
Dis Colon Rectum. 1991 Feb;34(2):119-25.

1990

1 – Amelioration of cholinergic-induced pancreatitis with a selective cholecystokinin receptor antagonist.
Bilchik AJ, Zucker KA, Adrian TE, Modlin IM.
Arch Surg. 1990 Dec;125(12):1546-9.

2 – Experimental models of acute pancreatitis.
Bilchik AJ, Leach SD, Zucker KA, Modlin IM.
J Surg Res. 1990 Jun;48(6):639-47. Review.

3 – Intra-ocular transplantation of carcinoid tumours from mastomys and humans.
Nilsson O, Bilchik AJ, Adrian TE, Modlin IM.
J Pathol. 1990 Apr;160(4):347-56.

4 – Significance of gastric endocrine tumor and age-related gut peptide alterations in Mastomys.
Bilchik AJ, Nilsson O, Modlin IM, Zucker KA, Adrian TE.
Regul Pept. 1990 Feb 4;27(2):195-207.

5 – A novel micromethod for pancreatic acinar secretion. Time course of CCK stimulation and its inhibition by L-364,718.
Adrian TE, Zucker KA, Bilchik AJ, Modlin IM.
Int J Pancreatol. 1990 Jan;6(1):61-9.

1989

1 – H2-receptor blockade induces peptide YY and enteroglucagon-secreting gastric carcinoids in mastomys.
Bilchik AJ, Nilsson O, Modlin IM, Sussman J, Zucker KA, Adrian TE.
Surgery. 1989 Dec;106(6):1119-26; discussion 1026-7.

2 – Deoxycholate-stimulated release of peptide YY from the isolated perfused rabbit left colon.
Ballantyne GH, Longo WE, Savoca PE, Adrian TE, Vukasin AP, Bilchik AJ, Sussman J, Modlin IM.
Am J Physiol. 1989 Nov;257(5 Pt 1):G715-24.

3 – Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals.
Zucker KA, Adrian TE, Bilchik AJ, Modlin IM.
Am J Physiol. 1989 Oct;257(4 Pt 1):G511-6.

4 – Cholecystokinin augmentation of ‘surgical’ pancreatitis. Benefits of receptor blockade.
Modlin IM, Bilchik AJ, Zucker KA, Adrian TE, Sussman J, Graham SM.
Arch Surg. 1989 May;124(5):574-8.

5 – Malignant diathesis from jejunal-ileal carcinoids.
Zucker KA, Longo WE, Modlin IM, Bilchik AJ, Adrian TE.
Am J Gastroenterol. 1989 Feb;84(2):182-6. Review.

6 – Does vasoactive intestinal polypeptide mediate the pathophysiology of bowel obstruction?
Basson MD, Fielding LP, Bilchik AJ, Zucker KA, Ballantyne GH, Sussman J, Adrian TE, Modlin IM.
Am J Surg. 1989 Jan;157(1):109-15.

7 – Prostaglandin E analogue inhibition of pancreatic enzyme secretion.
Zucker KA, Bilchik AJ, Modlin IM, Adrian TE.
Pancreas. 1989;4(6):708-14.

1988

1 – Advanced rectal cancer. What is the best palliation?
Longo WE, Ballantyne GH, Bilchik AJ, Modlin IM.
Dis Colon Rectum. 1988 Nov;31(11):842-7.

2 – Fine needle aspiration cytology of mucinous cystadenocarcinoma of the pancreas. Further observations.
Vellet D, Leiman G, Mair S, Bilchik A.
Acta Cytol. 1988 Jan-Feb;32(1):43-8.